4163.TWO · INTAI
Taiwan · RS rating 77 · As of 2026-10-08
| Price | 135.50 TWD |
|---|---|
| 1-day change | +1.1% |
| RS rating (overall / 1M / 3M / 12M) | 77 / 36 / 77 / 73 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 47 / 49 / 52 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | +27.9% |
| Sales growth Q/Q | +9.4% |
| Distance from 52-week high | +9.7% |
| Market cap (USD) | $217.4M |